Nucleoside Analog Antifungal Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Nucleoside Analog Antifungal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Ltd | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 213665-002 | May 1, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novel Labs Inc | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 204652-001 | Jul 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novel Labs Inc | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 204652-002 | Jul 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Strides Pharma | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 212632-001 | Apr 17, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Strides Pharma | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 212632-002 | Apr 17, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |